Abstract
This study was carried out to see the effect of the aqueous extract ofOcitum sanctum Linn (Tulsi) with Vitamin E on biochemical parameters and retinopathy in the streptozotocin-induced diabetic albino male rats. Adult albino male rats weighing 150–200 gm were made diabetic by intraperitoneal injection of streptozotocin in the dose 60 mg/kg in citrate buffer (pH 6.3). The diabetic animals were left for one month to develop retinopathy. Biochemical parameters like plasma glucose, oral glucose tolerance and glycosylated hemoglobin HbA1c, were measured along with lipid profile, and enzymes like glutathione peroxidase (GPX), lipid peroxidase (LPO), superoxide dismutase (SOD), catalase (CAT) and glutathione-S-transferase (GST) in normal, untreated diabetic rats and diabetic rats treated withOcimum sanctum L extracts and vitamin E. Fluorescein angiography test was done for assessing retinopathy. Results on biochemical parameters were analyzed statistically by using ANOVA followed by Dunnet's ‘t’-test. A p-value of <0.05 was considered as significant. Evaluation of biochemical profile in treated groups showed statistically significant reduction in plasma levels of glucose, HbA1c, lipid profile and LPO, and elevation of GPX, SOD, CAT and GST. Treatment of the diabetic animals withOcimum sanctum and Vitamin E, alone and in combination for 16 weeks showed reversal of most of the parameters studied including plasma glucose levels. Angiography showed improvement in retinal changes following combined antidiabetic treatment.
Key Words: Ocimum sanctum, Vitamin E, Diabetes mellitus, Diabetic retinopathy, Lipid peroxidation, Antioxidants
Full Text
The Full Text of this article is available as a PDF (117.8 KB).
Contributor Information
Eshrat M. Halim, Email: halim222003@yahoo.co.in
A. K. Mukhopadhyay, Email: mukhoak55@hotmail.com
References
- 1.Robert N., Frank Diabetic Retinopathy. New England Journal of Medicine. 2004;350:48–58. doi: 10.1056/NEJMra021678. [DOI] [PubMed] [Google Scholar]
- 2.Klein R., Klein B.E.K. Diabetes in America. 2nd ed. Bethesda, M D: National Diabetes Data Group; 1995. Vision disorders in diabetes; pp. 293–338. [Google Scholar]
- 3.Rahi J. S., Sripathi S., Gilbert C.E., Foster A. Child hood blindness in India: Causes in 1318 blind school children in nine states. Eye. 1995;9:545–550. doi: 10.1038/eye.1995.137. [DOI] [PubMed] [Google Scholar]
- 4.Riordan E. P, Eye . In: In current Medical Diagnosis and Treatment. 42nd ed. Tierney L. M., Mcphee S. J., Papadakis M.A., editors. New York: Lange Medical Books Mc Graw-Hill; 2003. pp. 177–1778. [Google Scholar]
- 5.Kumar A. Diabetic blindness in India, The emerging scenario. Indian J Ophthalmol. 1998;46:65–69. [PubMed] [Google Scholar]
- 6.Harris M., Hadden W.C., Knowles W.C., Bennett P.H. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20–74 yr. Diabetes. 1987;36:523–534. doi: 10.2337/diabetes.36.4.523. [DOI] [PubMed] [Google Scholar]
- 7.U K Prospective. Diabetes Study Group Intensive blood—glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in- patients with type 2 diabetes (UKPDS33) Lancet. 1998;352:837–853. doi: 10.1016/S0140-6736(05)61359-1. [DOI] [PubMed] [Google Scholar]
- 8.Jain S. K. Should high—dose vitamin E supplementation be recommended to patients? Diabetes Care. 1999;22(8):1242–1244. doi: 10.2337/diacare.22.8.1242. [DOI] [PubMed] [Google Scholar]
- 9.Sivaram P. In: New Developments in cardiology and cardiac surgery. Tehran N., Kumar A., editors. New Delhi: Escort Heart Institute and Research Center; 1994. pp. 1–1. [Google Scholar]
- 10.Jain S.K. The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids, suppl S. 1996;86:90–94. doi: 10.1007/BF02637057. [DOI] [PubMed] [Google Scholar]
- 11.Eshrat Halim M.A. Hussain, Jamil Kaiser, Rao Mala. Hypoglycemic, Hypolipidemic and antioxidant properties of Tulsi (Ocimum sanctum Linn) on streptozotocin induced diabetes in rats. Ind J Clin Biochem. 2001;2:190–194. doi: 10.1007/BF02864859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Eshrat H. M. Reversal of diabetic retinopathy in streptozotocin induced diabetic rats using traditional Indian antidiabetic plant,Azadirachta indica (L.) Ind. J. Clin. Biochem. 2002;17:115–123. doi: 10.1007/BF02867983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Eshrat H. M. Lowering of blood sugar by water extract ofAzadirachta indica andAbroma augusta in diabetes rats. Ind.J. Exp. Biol. 2003;41:636–640. [PubMed] [Google Scholar]
- 14.Beers R.F., Sizer L.W. A spectro photometric method for measuring the break break down of hydrogen peroxide by catalase. J. Biol. Chem. 1952;195:133–133. [PubMed] [Google Scholar]
- 15.Aeibi H., Catalase . In: Methods in Enzymatic Analysis. Berg H.U., Meyer, editors. New York: Academic Press; 1974. pp. 673–684. [Google Scholar]
- 16.Saxena A.K., Srivastava P., Kale R.K., Baqer N.Z. Impaired antioxidant status in diabetic rat liver: Effect of vanadate. Biochem Pharmacol. 1993;45:539–542. doi: 10.1016/0006-2952(93)90124-F. [DOI] [PubMed] [Google Scholar]
- 17.Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium deficient rat liver. Biochem Biophys Res Commun. 1976;71:952–958. doi: 10.1016/0006-291X(76)90747-6. [DOI] [PubMed] [Google Scholar]
- 18.Gupta D., Raju J., Prakash J., Baquer N.Z. Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats; effect of a insulin and vanadate. Diabetes Res. Clin. Pract. 1999;46:1–7. doi: 10.1016/S0168-8227(99)00067-4. [DOI] [PubMed] [Google Scholar]
- 19.Halim E. M. Hypoglycemic Hypolipidemic and antioxidant properties of combination ofCurcumin fromCurcuma Longa, Linn and partially purified product fromAbroma Augusta, Linn, in streptozotocin induced diabetes. Ind. J. Clin. Biochem. 2002;17:33–43. doi: 10.1007/BF02867969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbioturic acid reaction. Analytical Biochemistry. 1979;95:351–358. doi: 10.1016/0003-2697(79)90738-3. [DOI] [PubMed] [Google Scholar]
- 21.Lowry W.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin Phenol reagent. J Biol Chem. 1951;193:265–275. [PubMed] [Google Scholar]
- 22.Friedewald W.T., Levy R.I., Fred Rickson D.S. Estimation of the concentration of low—density Lipoprotein in cholesterol in plasma without use of the preparative a ultracentrifuge. Clin Chem. 1972;18(6):499–500. [PubMed] [Google Scholar]
- 23.Hyvarinen L, Hochheimer B. F. Filter systems in fluorescein angiography. Int Ophthalmol Clin. 1974;14(3):49–61. doi: 10.1097/00004397-197401430-00006. [DOI] [PubMed] [Google Scholar]
- 24.Wilkinson C.P. The clinical examination. Limitation and over utilization of Angiographic services. Ophthalmology. 1986;93:410–404. doi: 10.1016/s0161-6420(86)33750-3. [DOI] [PubMed] [Google Scholar]
- 25.Garg M.C., Ojha S., Bansal D.D. Antioxidant status of streptozotocin diabetic rats. Ind. J. Exp. Biol. 1996;34:264–266. [PubMed] [Google Scholar]
- 26.Wolff S. P., Dean R. T. Glucose autoxidation and protein modification: The potential role of ‘auto oxidative glycosylation’ in diabetes. Biochem J. 1987;245:243–250. doi: 10.1042/bj2450243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.The PKC-DRS Study Group Initial Results of the Protein Kinase C b Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial Diabetes. 2005;54:2188–2197. doi: 10.2337/diabetes.54.7.2188. [DOI] [PubMed] [Google Scholar]
- 28.Cusick M., Chew E.Y., Clemons T.E., Klein R., Klein B.E.K., Hubbard L.D. Effect of antioxidant and Zinc supplements on development of diabetic retinopathy in the Age Related Eye Disease Study (AREDS) Invest Ophthalmol Vis Sci. 2002;43:E 1909–E 1909. [Google Scholar]
- 29.Hammes H. P., Xueliang Du, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003;9:294–299. doi: 10.1038/nm834. [DOI] [PubMed] [Google Scholar]
- 30.The Diabetes Control and Complications Trial Research Group Clustering of Long-Term Complications in Families With Diabetes in the Diabetes Control and Complications Trial. Diabetes. 1997;46:1829–1839. doi: 10.2337/diabetes.46.11.1829. [DOI] [PubMed] [Google Scholar]
- 31.Sarkar A., Lavania S.C., Pandy D.N., Pant M.C. Changes in the blood lipid profile after administration ofOcimum sanctum (Tulsi) leaves in the normal albino rabbits. Indian J Physiol Pharmacol. 1994;38(4):311–2. [PubMed] [Google Scholar]
- 32.Baynes J., Thorpe S. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes. 1999;48:1–9. doi: 10.2337/diabetes.48.1.1. [DOI] [PubMed] [Google Scholar]
- 33.Yanpallewar S.U., Raj S., Kumar M., Achary A. Evaluation of antioxidant and neuroprotective effect ofOcimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Biochem Behar. 2004;79(1):155–164. doi: 10.1016/j.pbb.2004.07.008. [DOI] [PubMed] [Google Scholar]
- 34.Sood S., Narang D., Dinda A. K., Maulik S. K. Chronic oral administration ofOcimum snctum Linn augments cardac endogenous antioxidants and prevents Isoproterenol induced myocardial necrosis in rats. J Pharm Pharmacol. 2005;57(1):127–133. doi: 10.1211/0022357055146. [DOI] [PubMed] [Google Scholar]
- 35.Gupta S.K., Srivastava S., Trivedi D, Joshi S., Halder N. Ocimum sanctum modulates selenite—induced cataractogenic damage and prevents rat lens opacification. Curr Eye Res. 2005;30(7):583–591. doi: 10.1080/02713680590968132. [DOI] [PubMed] [Google Scholar]
- 36.Geetha R. K., Vasudevan D.M. Inhibition of lipid peroxidation by botanical extracts ofOcimum sanctum: in vivo and in Vitro studies. Life Sci. 2004;76(1):21–28. doi: 10.1016/j.lfs.2004.05.036. [DOI] [PubMed] [Google Scholar]
